Suppr超能文献

通过同步辐射小角X射线散射研究制备抗癌药物介导的普朗尼克共聚物自组装及其结构表征

Preparation, Structural Characterization of Anti-Cancer Drugs-Mediated Self-Assembly from the Pluronic Copolymers through Synchrotron SAXS Investigation.

作者信息

Lin Tz-Feng, Wang Wei-Chieh, Zeng Xin-Yu, Lu Yi-Xian, Shih Pei-Jung

机构信息

Department of Fiber and Composite Materials, Feng Chia University, Taichung 407, Taiwan.

Master's Program of Biomedical Informatics and Biomedical Engineering, Feng Chia University, Taichung 407, Taiwan.

出版信息

Materials (Basel). 2022 Aug 5;15(15):5387. doi: 10.3390/ma15155387.

Abstract

Chemotherapy drugs are mainly administered via intravenous injection or oral administration in a very a high dosage. If there is a targeted drug vehicle which can be deployed on the tumor, the medical treatment is specific and precise. Binary mixing of biocompatible Pluronic F127 and Pluronic L121 was used in this study for a drug carrier of pluronic biomedical hydrogels (PBHs). Based on the same PBH ingredients, the addition of fluorouracil (5-FU) was separated in three ways when it was incorporated with pluronics: F127-L121-(5-FU), F127-(5-FU), and L121-(5-FU). Small angle X-ray scattering experiments were performed to uncover the self-assembled structures of the PBHs. Meanwhile, the expected micelle and lamellar structural changes affected by the distribution of 5-FU were discussed with respect to the corresponding drug release monitoring. PBH-all with the mixing method of F127-L121-(5-FU) has the fastest drug release rate owing to the undulated amphiphilic boundary. In contrast, PBH-2 with the mixing method of L121-(5-FU) has a prolonged drug release rate at 67% for one month of the continuous drug release experiment because the flat lamellar amphiphilic boundary of PBH-2 drags the migration of 5-FU from the hydrophobic core. Therefore, the PBHs developed in the study possess great potential for targeted delivery and successfully served as a microenvironment model to elucidate the diffusion pathway of 5-FU.

摘要

化疗药物主要通过静脉注射或口服的方式以非常高的剂量给药。如果有一种能够部署在肿瘤上的靶向药物载体,那么治疗将具有特异性和精确性。本研究采用生物相容性的普朗尼克F127和普朗尼克L121二元混合来制备普朗尼克生物医学水凝胶(PBH)药物载体。基于相同的PBH成分,当氟尿嘧啶(5-FU)与普朗尼克混合时,以三种方式进行分离:F127-L121-(5-FU)、F127-(5-FU)和L121-(5-FU)。进行小角X射线散射实验以揭示PBH的自组装结构。同时,针对相应的药物释放监测,讨论了受5-FU分布影响的预期胶束和层状结构变化。由于起伏的两亲边界,采用F127-L121-(5-FU)混合方法的PBH-1具有最快的药物释放速率。相比之下,采用L121-(5-FU)混合方法的PBH-2在连续药物释放实验的一个月内药物释放速率延长至67%,因为PBH-2的扁平层状两亲边界阻碍了5-FU从疏水核心的迁移。因此,本研究中开发的PBH在靶向递送方面具有巨大潜力,并成功地作为微环境模型来阐明5-FU的扩散途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dfa/9369513/6bda274f8e0d/materials-15-05387-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验